Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
3 studies found for:    NIAID | Open Studies | Exclude Unknown | streptococcus group A OR cellulitis OR erysipelas OR impetigo OR scarlet fever OR bacteremia OR toxic shock syndrome OR necrotizing fasciitis
Show Display Options
Rank Status Study
1 Recruiting Phase I STEBVax in Healthy Adults
Condition: Toxic Shock Syndrome Staphylococcal
Interventions: Biological: STEBVax vaccine;   Drug: Aluminum hydroxide
2 Recruiting Virulence Determinants in S Aureus Bacteremia
Condition: Bacteremia
Intervention: Other: No intervention
3 Recruiting Uncomplicated Skin and Soft Tissue Infections Caused by Community-Associated Methicillin-Resistant Staphylococcus Aureus
Condition: Staphylococcal Infection
Interventions: Drug: Clindamycin;   Drug: Trimethoprim-sulfamethoxazole (TS);   Drug: Placebo

Indicates status has not been verified in more than two years